GlassScriptPhysician profile
Ashlee Koronka
NPI 1841830494
$7,995.83
in general payments reported to CMS, 2019-2025
61 companies · $26.96 in 2025
The $26.96 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,575 · 2022: $2,104 · 2023: $2,002 · 2024: $1,287 · 2025: $26.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,665 · Education: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,664.96 |
| Education | $651.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $770.23 | 2021-2025 | Piqray, Kisqali |
| Janssen Biotech, INC. | $672.58 | 2021-2023 | Erleada, Rybrevant |
| Pfizer INC. | $525.86 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $473.97 | 2021-2024 | Lynparza, Imfinzi, Enhertu |
| Astellas Pharma US INC | $455.55 | 2021-2024 | Padcev, Xtandi |
| Merck Sharp & Dohme LLC | $417.78 | 2021-2024 | Keytruda, Lynparza |
| Lilly USA, LLC | $406.74 | 2021-2024 | Retevmo, Verzenio, Jaypirca |
| Genzyme Corporation | $371.16 | 2021-2024 | |
| Asd Specialty Healthcare, LLC | $279.00 | 2021-2022 | |
| Kite Pharma, INC. | $256.06 | 2021-2023 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $213.42 | 2021-2024 | |
| Celgene Corporation | $168.11 | 2022-2024 | Reblozyl |
| Incyte Corporation | $160.21 | 2023-2024 | Jakafi |
| Amgen INC. | $154.34 | 2021-2023 | Prolia, Evenity |
| Gilead Sciences, INC. | $150.60 | 2022-2024 |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlee Koronka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.